In a move to strengthen its position in the diabetes market, Medtronic (Dublin) has formed an agreement with DreaMed Diabetes (Petah Tikvah, Israel), for the development and marketing of products incorporating DreaMed's MD-Logic Artificial Pancreas algorithm in the med-tech giant's insulin pumps. Read More
